The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
Open accessAbstract
BACKGROUND: One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, which could limit the value of any HIV-1 vaccine candidate currently under test. METHODOLOGY AND FINDINGS: To address the HIV-1 variation, we designed a novel T cell immunogen, designated HIV(CONSV), by assembling the 14 most conserved regions of the HIV-1 proteome into one chimaeric protein. Each segment is a consensus sequence from one of the four major HIV-1 clades A, B, C and D, which alternate to ensure equal clade coverage. The gene coding for the HIV(CONSV) protein was inserted into the three most studied vaccine vectors, plasmid DNA, human adenovirus serotype 5 and modified vaccine virus Ankara (MVA), and induced HIV-1-specific T cell responses in mice. We also demonstrated that these conserved regions prime CD8(+) and CD4(+) T cell to highly conserved epitopes in humans and that these epitopes, although usually subdominant, generate memory T cells in patients during natural HIV-1 infection. SIGNIFICANCE: Therefore, this vaccine approach provides an attractive and testable alternative for overcoming the HIV-1 variability, while focusing T cell responses on regions of the virus that are less likely to mutate and escape. Furthermore, this approach has merit in the simplicity of design and delivery, requiring only a single immunogen to provide extensive coverage of global HIV-1 population diversity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Diversity Considerations in HIV-1 Vaccine Selection
Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., et al. (2002) · Science · doi:10.1126/science.1070441 · Cited by 811
Self-citationHIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level
Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S., & Mallal, S. A. (2002) · Science · doi:10.1126/science.1069660 · Cited by 740
Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., Carli, M. D., Fiaccadori, F., & Ferrari, C. (1994) · Nature · doi:10.1038/369407a0 · Cited by 540
Evolutionary and immunological implications of contemporary HIV-1 variation
Korber, B., Gaschen, B., Yusim, K., Thakallapally, R., Kesmir, C., & Detours, V. (2001) · British Medical Bulletin · doi:10.1093/bmb/58.1.19 · Cited by 540
Self-citationHIV and SIV CTL escape: implications for vaccine design
Goulder, P. J. R., & Watkins, D. I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1417 · Cited by 500
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Fischer, W., Perkins, S., Theiler, J., Bhattacharya, T., Yusim, K., Funkhouser, R., Kuiken, C., Haynes, B., Letvin, N. L., Walker, B. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1461 · Cited by 446
Self-citationRowland-Jones, S. L., Dong, T., Fowke, K. R., Kimani, J., Krausa, P., Newell, H., Blanchard, T., Ariyoshi, K., Oyugi, J., Ngugi, E., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4314 · Cited by 421
Self-citationCytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants
Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Köppe, B., Rosenberg, W., Boyd, D., Edwards, A., et al. (1994) · Nature · doi:10.1038/369403a0 · Cited by 412
Self-citationTakahashi, H., Cohen, J., Hosmalin, A., Cease, K. B., Houghten, R., Cornette, J. L., DeLisi, C., Moss, B., Germain, R. N., & Berzofsky, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3105 · Cited by 409
Catanzaro, A. T., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509258 · Cited by 321
André, S., Seed, B., Eberle, J., Schraut, W., Bültmann, A., & Haas, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1497-1503.1998 · Cited by 305
Association of Malaria Parasite Population Structure, HLA, and Immunological Antagonism
Gilbert, S. C., Plebanski, M., Gupta, S., Morris, J., Cox, M., Aidoo, M., Kwiatkowski, D., Greenwood, B. M., Whittle, H. C., & Hill, A. V. S. (1998) · Science · doi:10.1126/science.279.5354.1173 · Cited by 279
Gallimore, A. (1998) · Journal of Experimental Medicine · doi:10.1084/jem.187.10.1647 · Cited by 259
Goulder, P. J. R., Altfeld, M. A., Rosenberg, E. S., Nguyen, T., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Muckerjee, J. S., Phillips, M. N., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.181 · Cited by 255
McMichael, A. J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090605 · Cited by 246
Self-citationFounder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations
Bhattacharya, T., Daniels, M., Heckerman, D., Foley, B., Frahm, N., Kadie, C., Carlson, J., Yusim, K., McMahon, B., Gaschen, B., et al. (2007) · Science · doi:10.1126/science.1131528 · Cited by 242
Self-citationGoonetilleke, N., Moore, S., Dally, L., Winstone, N., Cebere, I., Mahmoud, A., Pinheiro, S., Gillespie, G., Brown, D., Loach, V., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4717-4728.2006 · Cited by 236
Self-citationAllen, T. M., Sidney, J., del Guercio, M.-F., Glickman, R. L., Lensmeyer, G. L., Wiebe, D. A., DeMars, R., Pauza, C. D., Johnson, R. P., Sette, A., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6062 · Cited by 230
Frahm, N., Kiepiela, P., Adams, S., Linde, C. H., Hewitt, H. S., Sango, K., Feeney, M. E., Addo, M. M., Lichterfeld, M., Lahaie, M. P., et al. (2006) · Nature Immunology · doi:10.1038/ni1281 · Cited by 226
Self-citationPhase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine
Graham, B. S., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Martin, J. E., McCluskey, M. M., Chakrabarti, B. K., Lamoreaux, L., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509259 · Cited by 223
Gao, F., Weaver, E. A., Lu, Z., Li, Y., Liao, H.-X., Ma, B., Alam, S. M., Scearce, R. M., Sutherland, L. L., Yu, J.-S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1154-1163.2005 · Cited by 200
Self-citationJohnson, R. P., Trocha, A., Yang, L., Mazzara, G. P., Panicali, D. L., Buchanan, T. M., & Walker, B. D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1512 · Cited by 185
Burrows, S. R., Silins, S. L., Moss, D. J., Khanna, R., Misko, I. S., & Argaet, V. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1703 · Cited by 181
T Cell Cross-Reactivity and Conformational Changes during TCR Engagement
Lee, J. K., Stewart-Jones, G., Dong, T., Harlos, K., Di Gleria, K., Dorrell, L., Douek, D. C., van der Merwe, P. A., Jones, E. Y., & McMichael, A. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041251 · Cited by 161
Self-citationHanke, T., Szawlowski, P. W. S., & Randall, R. E. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-3-653 · Cited by 148
Self-citationAltfeld, M. A., Addo, M. M., Shankarappa, R., Lee, P. K., Allen, T. M., Yu, X. G., Rathod, A., Harlow, J., O’Sullivan, K., Johnston, M. N., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7330-7340.2003 · Cited by 143
Self-citationDNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice
Hanke, T. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00296-x · Cited by 135
Self-citationSeaman, M. S., Xu, L., Beaudry, K. R., Martin, K. L., Beddall, M. H., Miura, A., Sambor, A., Chakrabarti, B. K., Huang, Y., Bailer, R. T., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2956-2963.2005 · Cited by 132
Johnson, R. P., Piechocka‐Trocha, A., Buchanan, T. M., & Walker, B. D. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.961 · Cited by 132
Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development
Williamson, C. E., Morris, L., Maughan, M. F., Ping, L., Dryga, S. A., Thomas, R. K., Reap, E. A., Cilliers, T., Harmelen, J. H. V., Pascual, Á., et al. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203762688649 · Cited by 125
Hanke, T., McMichael, A. J., & Dorrell, L. (2006) · Journal of General Virology · doi:10.1099/vir.0.82493-0 · Cited by 119
Self-citationGotch, F., McMichael, A. J., & Rothbard, J. B. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.6.2045 · Cited by 114
Self-citationHIV Vaccines: New Frontiers in Vaccine Development
Duerr, A. C., Wasserheit, J. N., & Corey, L. (2006) · Clinical Infectious Diseases · doi:10.1086/505979 · Cited by 112
Johnson, R. P., Piechocka‐Trocha, A., Buchanan, T. M., & Walker, B. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.438-445.1993 · Cited by 105
Wilson, C. C., McKinney, D. M., Anders, M., MaWhinney, S., Forster, J. E., Crimi, C., Southwood, S., Sette, A., Chesnut, R. W., Newman, M. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5611 · Cited by 103
Plebanski, M., Lee, E. A. M., Hannan, C. M., et al. (1999) · Nature Medicine · doi:10.1038/8444 · Cited by 102
Ancestral and consensus envelope immunogens for HIV-1 subtype C
Kothe, D. L., Li, Y., Decker, J. M., Bibollet‐Ruche, F., Zammit, K. P., Salazar, M. G., Chen, Y., Weng, Z., Weaver, E. A., Gao, F., et al. (2006) · Virology · doi:10.1016/j.virol.2006.05.011 · Cited by 96
Self-citationHIV: current opinion in escapology
Klenerman, P., Wu, Y., & Phillips, R. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00339-9 · Cited by 90
Hausmann, S., Biddison, W. E., Smith, K. J., Ding, Y.-H., Garboczi, D. N., Utz, U., Wiley, D. C., & Wucherpfennig, K. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5389 · Cited by 89
Dorrell, L., Yang, H., Ondondo, B., Dong, T., di Gleria, K., Suttill, A., Conlon, C. P., Brown, D., Williams, P., Bowness, P., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4705-4716.2006 · Cited by 86
Self-citationAntigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Kothe, D. L., Decker, J. M., Li, Y., Weng, Z., Bibollet‐Ruche, F., Zammit, K. P., Salazar, M. G., Chen, Y., Salazar-Gonzalez, J. F., Moldoveanu, Z., et al. (2006) · Virology · doi:10.1016/j.virol.2006.10.017 · Cited by 81
Self-citationWeaver, E. A., Lu, Z., Camacho, Z. T., Moukdar, F., Liao, H., Ma, B.-J., Muldoon, M. R., Theiler, J. P., Nabel, G. J., Letvin, N. L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.02484-05 · Cited by 78
Self-citationHarrer, E. G., Harrer, T., Barbosa, P., Feinberg, M. B., Johnson, R. P., Buchbinder, S., & Walker, B. D. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.2.476 · Cited by 78
Puryear, W. B., Gnanakaran, S., Foley, B. T., Doria‐Rose, N. A., Korber, B., & Haigwood, N. L. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.999-1014.2006 · Cited by 64
Self-citationReconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 Proteins
Rolland, M., Jensen, M. A., Nickle, D. C., Yan, J., Learn, G. H., Heath, L., Weiner, D. B., & Mullins, J. I. (2007) · Journal of Virology · doi:10.1128/jvi.02683-06 · Cited by 59
Ferrari, G., Kostyu, D. D., Cox, J. H., Dawson, D. V., Flores, J., Weinhold, K. J., & Osmanov, S. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/08892220050140982 · Cited by 52
Walker, B. D., & Goulder, P. (2000) · Nature · doi:10.1038/35030283 · Cited by 44
In vivo antagonism of a T cell response by an endogenously expressed ligand
Basu, D., Williams, C. B., & Allen, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14332 · Cited by 43
Larke, N. L., Im, E., Wagner, R., Williamson, C. E., Williamson, A., McMichael, A. J., & Hanke, T. (2007) · European Journal of Immunology · doi:10.1002/eji.200636711 · Cited by 36
Self-citationHIV T cell vaccines, the importance of clades
McMichael, A. J., Mwau, M., & Hanke, T. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00067-1 · Cited by 36
Self-citationSlyker, J. A., Lohman, B. L., Mbori‐Ngacha, D., Reilly, M., Wee, E. G., Dong, T., McMichael, A. J., Rowland‐Jones, S., Hanke, T., & John-Stewart, G. C. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.145 · Cited by 22
Self-citationImmunization against a dominant tumor antigen abrogates immunogenicity of the tumor.
Makki, A., Weidt, G., Blachère, N. E., Lefrançois, L., & Srivastava, P. K. (2002) · PubMed · Cited by 22
Amara, R. R., Sharma, S., Patel, M., Smith, J. M., Chennareddi, L. S., Herndon, J. G., & Robinson, H. L. (2005) · Virology · doi:10.1016/j.virol.2005.01.026 · Cited by 19
Kmieciak, D., Bednarek, I. A., Takiguchi, M., Wąsik, T. J., Bratosiewicz, J., Wierzbicki, A. T., Teppler, H., Pientka, J., Hsu, S. H., Kaneko, Y., et al. (1998) · International Immunology · doi:10.1093/intimm/10.12.1789 · Cited by 6
Cited by
The Challenge of HIV-1 Subtype Diversity
Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E., & Hammer, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706737 · Cited by 635
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Deng, K., Pertea, M., Rongvaux, A., Wang, L., Durand, C. M., Ghiaur, G., Lai, J., McHugh, H. L., Hao, H., Zhang, H., et al. (2015) · Nature · doi:10.1038/nature14053 · Cited by 504
The origin and diversity of the HIV-1 pandemic
Hemelaar, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.12.001 · Cited by 427
Barouch, D. H., Stephenson, K. E., Borducchi, E. N., Smith, K., Stanley, K., McNally, A. G., Liu, J., Abbink, P., Maxfield, L. F., Seaman, M. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.061 · Cited by 342
Self-citationCD8+ T cells in HIV control, cure and prevention
Collins, D. R., Gaiha, G. D., & Walker, B. D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0274-9 · Cited by 303
Metadata
- Authors
- Létourneau, S., Im, E.-J., Mashishi, T., Brereton, C., Bridgeman, A., Yang, H., Dorrell, L., Dong, T., Korber, B., McMichael, A. J., & Hanke, T.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-10-03
- Volume
- 2
- Issue
- 10
- Pages
- e984
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2044812530
- Cited by
- 281
- References
- 56
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.